Literature DB >> 16125954

The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer.

Toshihiko Ibaraki1, Michiko Muramatsu, Shinji Takai, Denan Jin, Hiroshi Maruyama, Tatsuhiko Orino, Takahiro Katsumata, Mizuo Miyazaki.   

Abstract

OBJECTIVE: There are two types of human mast cells, tryptase-positive mast cells (MC(T)) and tryptase- and chymase-positive mast cells (MC(TC)). Although MC(T) have been reported to be related to the generation of angiogenesis, little is known about the involvement of MC(TC) in tumor angiogenesis. In this study, to clarify the relationship between MC(TC) and lung cancer angiogenesis, we evaluated MC(TC), MC(T), and microvessel counts in normal, border, and central lung cancer regions.
METHODS: Tumor sections from 32 cases of adenocarcinoma and 13 cases of squamous cell carcinoma were immunostained for chymase to evaluate MC(TC), tryptase to evaluate MC(T,) and CD34 to evaluate microvessel counts.
RESULTS: Both MC(TC) and MC(T) counts in the border lung cancer region were significantly higher than in the central region, and the MC(TC) and MC(T) counts in the central region were significantly higher than those in the normal regions. The microvessel counts in the border region were higher than those in the central region. The ratio of MC(TC) to MC(T) in the border region, but not in the central region, was significantly higher than that in the normal region. In the border region, significant correlations not only between MC(T) and microvessel count, but also between MC(TC) and microvessel count were observed. In the central region, a significant correlation between MC(TC) and the microvessel count was observed, but there was no significant correlation between MC(T) and the microvessel count.
CONCLUSIONS: These findings suggest that MC(TC) may be involved in the pathogenesis of angiogenesis in lung cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125954     DOI: 10.1016/j.ejcts.2005.06.020

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  18 in total

Review 1.  Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.

Authors:  Adam J Bograd; Kei Suzuki; Eva Vertes; Christos Colovos; Eduardo A Morales; Michel Sadelain; Prasad S Adusumilli
Journal:  Cancer Immunol Immunother       Date:  2011-09-13       Impact factor: 6.968

2.  Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention.

Authors:  Michele Ammendola; Valeria Zuccalà; Rosa Patruno; Emilio Russo; Maria Luposella; Andrea Amorosi; Giuseppina Vescio; Giuseppe Sammarco; Severino Montemurro; Giovambattista De Sarro; Rosario Sacco; Girolamo Ranieri
Journal:  Updates Surg       Date:  2012-11-02

Review 3.  Mast cell chymase: morphofunctional characteristics.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2019-08-08       Impact factor: 4.304

4.  Mast cells and T-lymphocytes in juvenile angiofibromas.

Authors:  Olaf Wendler; Renate Schäfer; Bernhard Schick
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-20       Impact factor: 2.503

Review 5.  Possible biological and translational significance of mast cells density in colorectal cancer.

Authors:  Ilaria Marech; Michele Ammendola; Claudia Gadaleta; Nicola Zizzo; Caroline Oakley; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 6.  Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.

Authors:  Louis J Dell'Italia; James F Collawn; Carlos M Ferrario
Journal:  Circ Res       Date:  2018-01-19       Impact factor: 17.367

7.  Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases.

Authors:  Ashish B Rajput; Dmitry A Turbin; Maggie Cu Cheang; David K Voduc; Sam Leung; Karen A Gelmon; C Blake Gilks; David G Huntsman
Journal:  Breast Cancer Res Treat       Date:  2007-03-13       Impact factor: 4.872

8.  Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact.

Authors:  G Alì; L Boldrini; M Lucchi; A Picchi; M Dell'Omodarme; M C Prati; A Mussi; V Corsi; G Fontanini
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

9.  Tryptase promotes atherosclerotic plaque haemorrhage in ApoE-/- mice.

Authors:  Xiuling Zhi; Chen Xu; Hao Zhang; Dai Tian; Xiaobo Li; Yanxia Ning; Lianhua Yin
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

Review 10.  Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma.

Authors:  Ilaria Marech; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  Int J Mol Sci       Date:  2014-07-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.